Tempus AI (NASDAQ:TEM) Trading 5.4% Higher - What's Next?

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s share price shot up 5.4% on Friday . The company traded as high as $36.20 and last traded at $36.10. 945,839 shares were traded during trading, a decline of 52% from the average session volume of 1,990,661 shares. The stock had previously closed at $34.25.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Stifel Nicolaus cut Tempus AI from a "buy" rating to a "hold" rating and raised their target price for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Wolfe Research initiated coverage on shares of Tempus AI in a research note on Friday, December 13th. They set an "outperform" rating and a $60.00 target price for the company. Piper Sandler restated a "neutral" rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Bank of America boosted their price objective on Tempus AI from $52.00 to $54.00 and gave the stock a "neutral" rating in a research report on Friday, December 13th. Finally, Guggenheim began coverage on Tempus AI in a report on Monday, December 9th. They issued a "buy" rating and a $74.00 price objective for the company. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $56.00.

Tempus AI Stock Up 11.7 %

The business's 50-day moving average is $48.93 and its 200-day moving average is $46.63. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Insider Transactions at Tempus AI

In related news, major shareholder Bradley A. Keywell sold 395,800 shares of the firm's stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total value of $16,999,610.00. Following the completion of the sale, the insider now owns 16,164,449 shares of the company's stock, valued at $694,263,084.55. This trade represents a 2.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director David R. Epstein sold 620 shares of the stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $41.81, for a total value of $25,922.20. Following the completion of the transaction, the director now owns 27,894 shares in the company, valued at $1,166,248.14. The trade was a 2.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 845,041 shares of company stock valued at $35,125,473.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Franklin Resources Inc. increased its stake in shares of Tempus AI by 1.0% in the 3rd quarter. Franklin Resources Inc. now owns 811,311 shares of the company's stock valued at $45,920,000 after acquiring an additional 8,387 shares during the last quarter. Tidal Investments LLC bought a new stake in Tempus AI in the third quarter valued at approximately $7,633,000. Teachers Retirement System of The State of Kentucky raised its holdings in Tempus AI by 6.3% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 126,500 shares of the company's stock worth $7,160,000 after purchasing an additional 7,500 shares during the period. Geode Capital Management LLC boosted its position in shares of Tempus AI by 0.4% during the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company's stock worth $7,537,000 after purchasing an additional 539 shares in the last quarter. Finally, XTX Topco Ltd acquired a new position in shares of Tempus AI in the 3rd quarter valued at $502,000. Institutional investors and hedge funds own 24.22% of the company's stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.